Chargement en cours...
Innovations in oligonucleotide drug delivery
Oligonucleotides (ONs) are a new class of therapeutic compounds under investigation for the treatment of a variety of disease states, such as cancer and HIV, and for FDA approval of an anti‐CMV retinitis antisense molecule (Vitravene™, Isis Pharmaceuticals). However, these molecules are limited not...
Enregistré dans:
| Publié dans: | J Pharm Sci |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley Subscription Services, Inc., A Wiley Company
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7094321/ https://ncbi.nlm.nih.gov/pubmed/12884243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.10399 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|